HOW LONG BEFORE MEN WILL BE TAKING THEIR DAILY ‘PILL’? Newsletter Article 12 February 2013 Pages: 2 - 3
ORAL ANTIDIABETIC AGENTS: HOW DO THEY STAND AFTER THE UGDP? Newsletter Article 12 February 2013 Pages: 3 - 3
TETRACYCLINES ARE STILL BEING USED IN YOUNG CHILDREN Newsletter Article 12 February 2013 Pages: 4 - 4
ARE ADVERSE DRUG EFFECTS RELATED TO IMPAIRED RENAL FUNCTION? Newsletter Article 12 February 2013 Pages: 6 - 6
CHLORDIAZEPOXIDE AGGRAVATES HYPERGLYCAEMIA IN A DIABETIC PATIENT Newsletter Article 12 February 2013 Pages: 7 - 7
DAPSONE + PYRIMETHAMINE SUPERIOR TO CHLOROQUINE FOR MALARIA Newsletter Article 12 February 2013 Pages: 7 - 8
‘LOCABIOTAL’ MERITS FURTHER STUDY IN NOSE AND THROAT INFECTIONS Newsletter Article 12 February 2013 Pages: 10 - 10
VILOXAZINE AND IMIPRAMINE IN MODERATELY DEPRESSED PATIENTS Newsletter Article 12 February 2013 Pages: 10 - 10
SALBUTAMOL SUPERIOR TO RIMITEROL IN CHRONIC AIRWAYS OBSTRUCTION Newsletter Article 12 February 2013 Pages: 10 - 10
INTRATHECAL ANTITETANUS HORSE SERUM REDUCES TETANUS MORTALITY Newsletter Article 12 February 2013 Pages: 11 - 11
D-NORGESTREL SILASTIC IMPLANTS PROMISE LONG-TERM CONTRACEPTION Newsletter Article 12 February 2013 Pages: 14 - 14
MINOXIDIL SHOWS PROMISE IN SEVERE REFRACTORY HYPERTENSION Newsletter Article 12 February 2013 Pages: 16 - 16
PROPER MANAGEMENT REDUCES RISK OF RIFAMPICIN REACTIONS Newsletter Article 12 February 2013 Pages: 17 - 18